- 1. coA
- [coenzyme that takes part in fatty acid metabolism. ( CSP )] (UMLS (CSP) C0009226) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=cofactor;
=acyl coA;
| - 21. coagulation factor II
- [plasma protein precursor of thrombin, converted to thrombin by a prothrombin activator complex; deficiency of prothrombin leads to hypoprothrombinemia. ( CSP )] (UMLS (CSP) C0033706) =Amino Acid, Peptide, or Protein; Biologically Active Substance =proenzyme;
|
- 2. coA analog
- [ ] (UMLS (CSP) C0598189) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
| - 22. Coagulation Factor II (Thrombin) Receptor Gene
- [This gene is involved in coagulation and proteolytic cleavage regulation. ( NCI )] (UMLS (NCI) C1366449) F2R;
F2R Gene =Gene or Genome |
- 3. coA transferase
- [Enzymes which transfer coenzyme A moieties from acyl- or acetyl-CoA to various carboxylic acceptors forming a thiol ester. Enzymes in this group are instrumental in ketone body metabolism and utilization of acetoacetate in mitochondria. EC 2.8.3. ( MSH )] (UMLS (CSP) C0009228) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 23. Coagulation Factor II Receptor
- [Expressed in platelets and vascular endothelia by human F2R Gene (GPCR1 Family), 425-aa 47-kDa (precursor) Coagulation Factor II Receptor is a 7-transmembrane G-protein coupled high affinity activated thrombin receptor that stimulates phosphoinositide hydrolysis in the cellular thrombotic response. F2R appears to play a role in platelet activation and vascular development. Receptor phosphorylation probably mediates desensitization prior to uncoupling and internalization. Activated protein C uses EPCR as a coreceptor for cleavage of Coagulation Factor II Receptor on endothelia. Proteolytic cleavage of F2R generates a new N-terminus that functions as a tethered ligand. (NCI) ( NCI )] (UMLS (NCI) C0668084) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 4. COAd/CO-5
- (UMLS (NCI) C0104713) =Therapeutic or Preventive Procedure
| - 24. Coagulation Factor III (Thromboplastin, Tissue Factor) Gene
- [This gene is involved in the blood coagulation process by initiating blood coagulation cascades. ( NCI )] (UMLS (NCI) C1333522) F3;
F3 Gene =Gene or Genome |
- 5. COAG FACTOR TRANSFUSION
- [ ] (UMLS (ICD9CM) C0199967) =Therapeutic or Preventive Procedure
| - 25. Coagulation Factor IX (Plasma Thromboplastic Component, Christmas Disease, Hemophilia B) Gene
- [This gene plays a role in the regulation of blood coagulation and is modulated by Ca+2 ions, membrane phospholipids, and factor VIII. ( NCI )] (UMLS (NCI) C1366464) F9;
F9 Gene =Gene or Genome ;
|
- 6. coagulant
- [Exogenous substances used to promote blood coagulation. The endogenous BLOOD COAGULATION FACTORS are considered to be coagulants only when administered as drugs. ( MSH )] (UMLS (CSP) C0009117) =Pharmacologic Substance
| - 26. Coagulation Factor VII (Serum Prothrombin Conversion Accelerator) Gene
- [This gene plays an essential role in the maintenance of cellular homeostasis. ( NCI )] (UMLS (NCI) C1333523) F7;
F7 Gene =Gene or Genome |
- 7. Coagulase-Positive Staphylococcus
- [A subtype of Staphylococcus characterized by an ability to produce free plasma coagulase. ( NCI )] (UMLS (NCI) C1265293) =Bacterium
| - 27. Coagulation Factor VIII, Procoagulant Component (Hemophilia A) Gene
- [This gene plays an important role in blood coagulation. ( NCI )] (UMLS (NCI) C1366370) F8;
F8 Gene =Gene or Genome |
- 8. COAGULAT DEFECT NEC/NOS
- [ ] (UMLS (ICD9CM) C0029496) =Disease or Syndrome
| - 28. coagulation factor XII
- [Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. ( MSH )] (UMLS (CSP) C0015525) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Blood Coagulation Factor;
Serine Endopeptidases |
- 9. Coagulation
- [Coagulation ( HL7V3.0 )] (UMLS (HL7) C1561952) =Health Care Activity =ObservationMethod;
| - 29. coagulation factor XIII
- [fibrin-stabilizing plasma transglutaminase that is activated by thrombin and calcium to form factor XIIIa; important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. ( CSP )] (UMLS (CSP) C0015528) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =Blood Coagulation Factor;
|
- 10. Coagulation (DIC), disseminated intravascular
- [disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels; the activation of the clotting mechanism may arise from any of a number of disorders; in the late stages, it is marked by profuse hemorrhaging. ( CSP )] (UMLS (NCI) C0012739) =Disease or Syndrome =blood coagulation disorder;
HEMORRHAGIC COND NOS;
Thrombophilia;
| - 30. coal
- [natural fossil fuel formed by partial decomposition of vegetable matter under certain environmental conditions. ( CSP )] (UMLS (CSP) C0009131) =Organic Chemical =fossil fuel energy;
|
- 11. Coagulation clinic
- (UMLS (HL7) C1552771) =Intellectual Product ;
=Outpatient facility;
| - 31. coal mining
- [ ] (UMLS (CSP) C0009133) =Occupational Activity
|
- 12. COAGULATION DEF-ANTEPART
- [ ] (UMLS (ICD9CM) C1719583) Coagulation defects complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication =Disease or Syndrome
| - 32. Coast Miwok
- (UMLS (HL7) C1551928) =Language =WesternMiwok;
|
- 13. COAGULATION DEF-DELIV
- [ ] (UMLS (ICD9CM) C1719581) Coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition =Disease or Syndrome
| - 33. coastal water
- [ ] (UMLS (CSP) C0442542) =Geographic Area ;
|
- 14. Coagulation defects complicating pregnancy, childbirth, or the puerperium
- [ ] (UMLS (ICD9CM) C1719585) =Disease or Syndrome
| - 34. coat (enveloped virus)
- [outermost layer of protein, lipid, and glycoconjugates surrounding the nucleocapsid of complex viruses. ( CSP )] (UMLS (CSP) C0178887) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=virus morphology;
|
- 15. Coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C1719582) COAGULATN DEF-DEL W P/P =Disease or Syndrome
| - 35. Coated Particles Tablet
- (UMLS (HL7) C1553202) =Biomedical or Dental Material =Oral Tablet;
|
- 16. Coagulation defects complicating pregnancy, childbirth, or the puerperium, postpartum condition or complication
- [ ] (UMLS (ICD9CM) C1719584) COAGULATION DEF-POSTPART =Disease or Syndrome
| - 36. Coated Pit
- [Specialized depressions on the cell surface involved in receptor-mediated endocytosis; the visible proteinaceous layer on the cytosolic side of the depression provides the coated appearance. ( NCI )] (UMLS (NCI) C0598180) =Cell Component
|
- 17. Coagulation defects complicating pregnancy, childbirth, or the puerperium, unspecified as to episode of care or not applicable
- [ ] (UMLS (ICD9CM) C1719580) COAGULATION DEF-UNSPEC =Disease or Syndrome
| - 37. Coated Tablet Dosage Form
- [A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI) ( NCI )] (UMLS (NCI) C1273642) Coated Tablet Dose Form;
TAB COATED;
TABLET, COATED =Biomedical or Dental Material |
- 18. Coagulation Factor Deficiency
- (UMLS (NCI) C0849773) =Disease or Syndrome
| - 38. Coated Vesicle
- [Vesicles formed when cell-membrane coated pits (COATED PITS, CELL-MEMBRANE) invaginate and pinch off. The outer surface of these vesicles are covered with a lattice-like network of coat proteins, such as CLATHRIN, coat protein complex proteins, or CAVEOLINS. ( MSH )] (UMLS (NCI) C0242915) =Cell Component ;
|
- 19. Coagulation Factor Gene
- [Coagulation Factor Genes encode endogenous Coagulation Factors, involved in blood coagulation. (NCI) ( NCI )] (UMLS (NCI) C1333075) =Gene or Genome ;
| - 39. coating
- [FDA label coating ( HL7V3.0 )] (UMLS (HL7) C1552080) =Intellectual Product =FDALabelData;
|
- 20. coagulation factor I
- [plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds; fibrinogen clotting is a sol-gel change involving complex molecular arrangements. ( CSP )] (UMLS (CSP) C0016006) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=acute phase protein;
Blood Coagulation Factor;
Protein Precursors;
=FIBRINOGEN,I-125 | - 40. coating
- [ Definition: A characteristic of an oral solid dosage form of a medicinal product, indicating whether it has one or more coatings such as sugar coating, film coating, or enteric coating. Only coatings to the external surface or the dosage form should be considered (for example, coatings to individual pellets or granules inside a capsule or tablet are excluded from consideration). Constraints: The Observation.value must be a Boolean (BL) with true for the presence or false for the absence of one or more coatings on a solid dosage form. ( HL7V3.0 )] (UMLS (HL7) C1697272) =Intellectual Product =ActCode;
|
home
